AlphaRx Introduces ``Flexogan & Flexigan'' the Next Generation of Topical Pain Relieving Products.Business Editors, Health & Medical Writers RICHMOND HILL, Ontario--(BW HealthWire)--Nov. 29, 2001 AlphaRx Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :AHRX) announced today that it will be launching 3 over-the-counter pain relieving products in North America under the trade name Flexogan Muscle Pain, Flexogan Arthritis Pain and Flexogan Phyto Power. These are deep-penetrating emulsions, scientifically formulated using the Company's BCD (Binary Coded Decimal) The storage of numbers in which each decimal digit is converted into binary and is stored in a single character or byte. For example, a 12-digit number would take 12 bytes. See binary numbers. delivery technology to provide fast, effective and long lasting relief from arthritis, joint and muscle pain. AlphaRx is also planning to launch its 1.0% Diclofenac emulsion in Europe, it will be marketed under the trade name Flexigan and will be available over-the-counter in most European countries. A recent study using carrageenan car·ra·geen·an or car·ra·geen·in n. Any of a group of closely related colloids derived from several red algae, widely used as a thickening, stabilizing, emulsifying, or suspending agent in pharmaceuticals. model of non-infective inflammation indicated that NSAID NSAID: see nonsteroidal anti-inflammatory drug. (Non Steroidal Non steroidal Not containing steroids or cortisone. Usually refers to a class of drugs called Non Steroidal Anti-Inflammatory Drugs (NSAID). Mentioned in: Antirheumatic Drugs Anti-inflammatory Drug) such as Diclofenac and Indomethacin indomethacin /in·do·meth·a·cin/ (in?do-meth´ah-sin) a nonsteroidal antiinflammatory drug; used in the treatment of various rheumatic and nonrheumatic inflammatory conditions, dysmenorrhea, and vascular headache. incorporated in the company's BCD system suppress induced inflammation up to 4 times more effectively than currently marketed brand products. Worldwide sales of non-steroidal anti-inflammatory drugs Non-steroidal anti-inflammatory drugs (NSAIDs) Aspirin, ibuprofen, naproxen, and many others. Mentioned in: Mastocytosis totaled approximately $6.5 billion in 2000 and are expected to grow at a 4% compound annual growth rate. USA Today estimates that American doctors write nearly 80 million prescriptions for NSAIDs annually. AlphaRx believes its topical pain management products can compete effectively and have a significant penetration in this market. AlphaRx has an extensive oral and topical pain management product pipeline in different stages of development. AlphaRx plans to be the first company to bring two prescription topical NSAID's - 2.0% Indomethacin and 1.5% Diclofenac in to North America. At present, there are no topical NSAIDs approved for marketing in North America and no pharmaceutical company has succeeded in obtaining market approval for a topical NSAID in North America. However, the Company is confident that its two prescription topical NSAIDs will gain market approval in North America because, unlike other competing products, they do not contain unsafe ingredients or synthetic penetration enhancers. FORWARD LOOKING STATEMENTS: This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion